Generics - Generics, Neurological

Filter

Current filters:

GenericsNeurological

Popular Filters

1 to 25 of 130 results

Actavis challenges Quillivant XR patent

16-10-2014

Ireland-headquartered generics major Actavis confirmed that it has filed an Abbreviated New Drug Application…

ActavisGenericsLegalNeurologicalPatentsPfizerQuillivantRegulationTris PharmaUSA

Teva’s Copaxone case heard again by US Supreme Court

Teva’s Copaxone case heard again by US Supreme Court

16-10-2014

The patent battle over Israel-based Teva Pharmaceutical Industries’ multiple sclerosis drug Copaxone…

CopaxoneGenericsLaw CrimeLegalMylanNeurologicalTevaUS Supreme CourtUSA

Supernus sues Actavis for Trokendi XR patents infringement

Supernus sues Actavis for Trokendi XR patents infringement

02-10-2014

USA-based specialty drug firm Supernus Pharmaceuticals says it has sued generic drugmaker Actavis and…

ActavisGenericsLegalNeurologicalPatentsSupernus PharmaceuticalsTrokendi XRUSA

Actavis confirms patent challenge for generic Neupro

Actavis confirms patent challenge for generic Neupro

23-08-2014

Ireland-headquartered generics major Actavis on Friday confirmed that it has filed an Abbreviated New…

ActavisGenericsLegalNeuproNeurologicalPatentsRegulationUCBUSA

Mylan awarded temporary restraining order against Apotex over Paxil generic

Mylan awarded temporary restraining order against Apotex over Paxil generic

23-07-2014

US generic drugmaker Mylan has announced that the US District Court for New Jersey granted its motion…

ApotexApotex IncCanadaGenericsLegalMylanNeurologicalparoxetinePaxil-CRSelective serotonin reuptake inhibitorsUS District Court for New JerseyUSA

US court preliminary order to prevent Actavis launch of generic Gralise

US court preliminary order to prevent Actavis launch of generic Gralise

18-07-2014

Judge Joel Pisano of the US District Court for the District of New Jersey has entered an order preliminarily…

ActavisActavis Elizabeth LLCAnticonvulsantsDepomedGenericsGraliseHealth Medical PharmaLaw CrimeLegalNeurologicalPatentsPfizerUSA

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

17-07-2014

US generics drug major Mylan says that the US District Court for the District of New Jersey granted its…

ApotexGenericsGlaxoSmithKlineLegalMylanNeurologicalparoxetinePaxil-CRUSA

Acorda fights Actavis on generic of its multiple sclerosis drug Ampyra

Acorda fights Actavis on generic of its multiple sclerosis drug Ampyra

09-07-2014

Ireland-headquartered generics major Actavis has confirmed filing an Abbreviated New Drug Application…

Acorda TherapeuticsActavisAmpyradalfampridineGenericsLegalNeurologicalUSA

Actavis settles Nuvigil patent litigation with Cephalon

Actavis settles Nuvigil patent litigation with Cephalon

01-06-2014

Ireland-headquartered generics major Actavis says it has entered into an agreement with Cephalon to settle…

ActavisCephalonGenericsLegalNeurologicalNuvigilPatentsTeva Pharmaceutical IndustriesUSA

Prasco to market authorized generic of NeoProfen Injection

22-05-2014

Privately held US generic drugmaker Prasco Laboratories has entered into a distribution and supply agreement…

GenericsLicensingNeoProfenNeurologicalPrasco LaboratoriesRecordatiUSA

US Court rejects Teva’s Copaxone appeal

15-05-2014

A US district court has dismissed a case by Israeli drugmaker Teva Pharmaceutical Industries intended…

CopaxoneGenericsLegalMylanNeurologicalPatentsTeva Pharmaceutical IndustriesUSA

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

14-05-2014

US generic drugmaker Mylan says it has launched Olanzapine Orally Disintegrating tablets (ODT), 5mg,…

ActavisEli LillyExalgoGenericsMallinckrodtMarkets & MarketingMylanNeurologicalRegulationUSAZyprexa

Teva files suit against US FDA over generic Copaxone

Teva files suit against US FDA over generic Copaxone

12-05-2014

Israel-based Teva Pharmaceutical Industries has complained to the US Food and Drug Administration that…

Business FinanceCopaxoneGenericsGlatiramer acetateHealth Medical PharmaLegalNeurologicalScience and technology in IsraelSocial IssuesTeva Pharmaceutical IndustriesUSA

Grunenthal strengthens pain product portfolio with European rights to etoricoxib

07-05-2014

Family-owned German drugmaker Grunenthal Group today announced the signing of an exclusive promotion…

etoricoxibEuropeGenericsGrunenthalLicensingMerck & CoNeurological

US Supreme Court denies Teva's request for injunction relating to Mylan’s generic Copaxone

21-04-2014

The US Supreme Court Chief Justice Roberts has denied Israeli generics giant Teva Pharmaceutical Industries’…

CopaxoneGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaPatentsTeva Pharmaceutical IndustriesUSA

Depomed settlements with two Gralise ANDA filers

15-04-2014

US specialty drugmaker Depomed has entered into settlement agreements with two of the three defendants…

DepomedGenericsGraliseIncepta PharmaceuticalsLegalNeurologicalNorth AmericaPatentsUSAZydus Cadila

US Judge enforces settlement deal between Mylan and Endo over generic Frova

US Judge enforces settlement deal between Mylan and Endo over generic Frova

11-04-2014

US generic major Mylan today confirmed that a federal district court has granted its request to enforce…

Endo Health SolutionsEndo PharmaceuticalsFrovaGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaPatentsUSA

Mylan prevails in breach of contract case against GlaxoSmithKline

Mylan prevails in breach of contract case against GlaxoSmithKline

27-03-2014

US generics major Mylan reveals that, after a trial in the US District Court for the District of New…

GenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalparoxetinePaxil-CR

Actavis in Daytrana patent settlement

Actavis in Daytrana patent settlement

20-03-2014

Generic drugs major Actavis has entered into an agreement with Noven Pharmaceuticals, a subsidiary of…

ActavisDaytranaGenericsHisamitsu PharmaLegalNeurologicalNorth AmericaNoven PharmaceuticalsPatentsUSA

Teva agrees $27.6 million settlement with US Justice Dept

Teva agrees $27.6 million settlement with US Justice Dept

12-03-2014

US subsidiaries of Israeli generics giant Teva Pharmaceutical Industries have agreed to pay the US government…

ClozapineFinancialGenericsIvaxLegalNeurologicalNorth AmericaTeva Pharmaceutical IndustriesUSA

Ranbaxy cleared to market branded generic of Aricept in Canada

Ranbaxy cleared to market branded generic of Aricept in Canada

08-01-2014

The Canadian subsidiary of Ranbaxy Laboratories has received approval to manufacture and market RAN-Donepezil…

AriceptCanadaDaiichi SankyoEisaiGenericsNeurologicalNorth AmericaRAN-DonepezilRanbaxy LaboratoriesRegulation

1 to 25 of 130 results

Back to top